HomeInsightsStock Comparison

Sigachi Industries Ltd vs Vaishali Pharma Ltd Stock Comparison

Sigachi Industries Ltd vs Vaishali Pharma Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Sigachi Industries Ltd is ₹ 36.35 as of 01 Aug 15:30.
  • The P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 32.1 on March 2024 . This represents a CAGR of 13.08% over 3 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1831 crore on March 2024 . This represents a CAGR of 27.26% over 3 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Sigachi Industries Ltd for the Jun '25 is ₹ 132.19 crore as compare to the Mar '25 revenue of ₹ 130.39 crore. This represent the growth of 1.38% The revenue of Vaishali Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Sigachi Industries Ltd for the Jun '25 is ₹ -92.96 crore as compare to the Mar '25 ebitda of ₹ 30.75 crore. This represent the decline of -402% The ebitda of Vaishali Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Sigachi Industries Ltd changed from ₹ 10.88 crore to ₹ -100 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Vaishali Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Sigachi Industries Ltd changed from 3.76 % on March 2020 to 8 % on March 2024 . This represents a CAGR of 16.30% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sigachi Industries Ltd

  • Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
  • To diversify the business activities, name of the Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
  • Subsequently, Company was converted from a Private Limited to a Public Limited and consequently, name was changed to 'Sigachi Industries Limited' effective on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
  • The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

About Vaishali Pharma Ltd

  • Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
  • On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
  • M/s.
  • Vaishali Pharmachem through Business Assignment agreement.
  • Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

Sigachi Industries Ltd News Hub

News

Sigachi Industries reports dismal Q1 outcome

However, revenue from operations jumped 34% year on year to Rs 128.25 crore in Q1 FY26. Th...

Read more

28 Jul 2025 11:09

News

Sigachi Industries commences operations of its newly established R&D center in Hyderabad

Sigachi Industries is set to strengthen its scientific and technical capabilities with the...

Read more

23 Jul 2025 09:43

News

Sigachi Industries to hold board meeting

Sigachi Industries will hold a meeting of the Board of Directors of the Company on 25 July...

Read more

22 Jul 2025 17:33

News

Sigachi Industries receives affirmation in credit ratings from CARE

Sigachi Industries has received reaffirmation in credit rating at 'CARE A-/ CARE A2' with ...

Read more

10 Jul 2025 17:03

News

Sigachi Industries board appoints Lijo Chacko as Deputy Group CEO

Lijo Chacko is the chief executive officer ' Middle East & Africa at Sigachi Industries. H...

Read more

07 Jul 2025 13:52

News

Sigachi Industries reports fire accident at Pashamylaram, Telangana

 Sigachi Industries press release on fire accident at Hyderabad: It is with anguish that w...

Read more

02 Jul 2025 12:07

Vaishali Pharma Ltd News Hub

News

Vaishali Pharma to convene board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

26 May 2025 18:27

News

Vaishali Pharma announces board meeting date

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 6 February...

Read more

01 Feb 2025 13:50

News

Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 January...

Read more

25 Jan 2025 10:31

News

Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

12 Nov 2024 10:39

News

Vaishali Pharma schedules board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October...

Read more

09 Oct 2024 10:17

News

Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October ...

Read more

25 Sep 2024 15:36

SWOT Analysis Of Vaishali Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sigachi Industries Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Vaishali Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sigachi Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sigachi Industries Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Sigachi Industries Ltd or Vaishali Pharma Ltd?

Market cap of Sigachi Industries Ltd is 1,389 Cr while Market cap of Vaishali Pharma Ltd is 136 Cr

What are the key factors driving the stock performance of Sigachi Industries Ltd and Vaishali Pharma Ltd?

The stock performance of Sigachi Industries Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sigachi Industries Ltd and Vaishali Pharma Ltd?

As of August 2, 2025, the Sigachi Industries Ltd stock price is INR ₹36.35. On the other hand, Vaishali Pharma Ltd stock price is INR ₹12.7.

How do dividend payouts of Sigachi Industries Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Sigachi Industries Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions